Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5536338 | Vaccine | 2017 | 8 Pages |
Abstract
Maternal Tdap vaccination between 27 and 36Â weeks of pregnancy was consistently protective against infant ARI in the first 2Â months of life vs no vaccination during pregnancy, regardless of Tdap vaccination prior to pregnancy. Our findings strongly support current ACIP guidelines recommending Tdap vaccination in late pregnancy for every pregnancy.
Keywords
DTaPCVXDMDCTdap vaccinationFHATdapEGADODARIICD-9-CMLMPlast menstrual periodVaccine effectivenessACIPEstimated gestational ageTetanus toxoid, reduced diphtheria toxoid, and acellular pertussisRegistryGEERelative riskCAIRpertussis toxinPertussisLocally weighted scatterplot smoothinginternational classification of diseases, ninth revision, clinical modificationAcute respiratory infectionconfidence intervalLowessgeneralized estimating equationodds ratioFilamentous hemagglutininDepartment of DefenseAdvisory Committee on Immunization Practices
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Zeina G. Khodr, Anna T. Bukowinski, Gia R. Gumbs, Ava Marie S. Conlin,